Life Science Nation Newsletter  | April 5,  2018  |  Issue 260

  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Consulting
Life Science Investor Mandates (Mar. 29 - Apr. 4 )
Focused on Data-Driven Life Science Technologies, from Devices to Computational Drug Discovery
Invests in North American Companies in Therapeutics, Medical Devices, Digital Health and Services
Establishes New Venture Fund for Investing in Early-Stage Digital Health Companies Globally
Seeks to Invest in Life Science Companies, with Focus on Cell/Gene Therapies, Antibodies, Synthetic Biology, etc.
In This Issue
Nature BioEntrepreneur Features LSN: Aligning Needs
LSN Services
LSN's Sourcing & Ranking Service (SRS) provides clients with an opportunity to quickly source, vet, rank and engage with partners that are licensing global technology assets.

Click to see investors that are a fit for your product and stage of development

Click here if you are a service provider and want to see a list of funded life science companies that are a fit for you

Click here if you want to receive free, targeted early stage dealflow for your life science investment firm

Free Copy of LSN's Book

LSN Videos
By Nono Hu, Director of Marketing, LSN

In 5 days, The Redefining Early Stage Investments (RESI) Conferencewill return to MaRS Discovery Centre, Toronto for the third time during the Toronto Health Innovation Week. So far, we have over 700 meetings booked through the RESI Partnering Platform, and have registered over 250 early stage investors. 

If you're planning your day at RESI on MaRS, check out the program guide now to find the full lineup of speakers, innovators, exhibitors and sponsors. 

See you at "MaRS" on April 10th!
By Dennis Ford, Founder & CEO, Life Science Nation; Creator of RESI Conference Series

There is a rich diversity of technology assets being developed in Toronto, as MaRS Discovery District and Johnson & Johnson's JLABS have convened to create one of the most dynamic centers for life science technology innovation in North America. However, not to use an old cliché, Toronto's real value in life science is in the people, from its visionary leaders to its extraordinary scientist-entrepreneurs, all striving (and succeeding) to move the needle and create the next generation of healthcare innovation.

When I first launched the Redefining Early Stage Investments (RESI) Conference in Toronto in 2016, my network of global early-stage investors were initially open to seeing what was up in the north country. Just two years and three Toronto RESI conferences later, I am witnessing unprecedented signups from the global investor community. Much to my amazement, this upcoming RESI conference (April 10th at MaRS Discovery Centre) has seen a 25% increase in investor and strategic partner registrations. We expect 300-350 qualified investors (all with vetted investment mandates) to peruse the lineup of hundreds of early-stage biotech, medtech, diagnostics and digital health startups. But one quite compelling factor is that we expect that almost 60% of the investors and partners will be from outside of Canada...

By Christine A. Wu, Senior Research Analyst, LSN

For every RESI event, the LSN Investor Research team aims to recruit a diverse slate of panels with experienced investors of all types and focus areas within life science technology. As one of the more highly sought types of investors for entrepreneurs, Family Offices is a recurring panel at RESI. Mostly backed by private wealth as evergreen funds, family offices often have deep connections in the life science field both professionally and, at times, personally-some family office investors have loved ones battling debilitating diseases. Family offices are highly idiosyncratic with their own motivations and strategies, though despite their differences and founding stories, they continue to play actively within life science investment.

On April 10th at RESI Toronto, we will hear from four family offices that invest in several different life science sectors. Moderated by Catherine Love, Director of Capital Services for MaRS Discovery District, the panelists include:
  • Sherry Grisewood, Chief Investment Office, Foxhill Asset Management
  • David Ramos, CFO, AGP Holdings
  • Chuck Stetson, CEO, Stetson Family Office
  • Oded Levi, President, Epstein Enterprises
By Sean Tran, Business Development Manager, LSN

The Life Science Nation team is pleased to announce the sponsors and exhibitors for our third RESI conference in Toronto. Attracting over 600 attendees, sponsors and exhibitors will be in the spotlight of our exhibition hall, standing out as leaders in the life science industry.

Twenty companies will participate in the Exhibition, displaying their products and services. The array of offerings from these exhibitors will give attending companies a chance to meet valuable partners to help move their technologies forward in development.


Title Sponsors

Gold Sponsors

Silver Sponsors

Bronze Sponsors

MaRS Supporters

Media Sponsors

Created & Produced by